Clinical Trials Browser

Locally Advanced Non-small Cell Lung Cancer

Carcinoma, Hepatocellular

Multiple Myeloma

Carcinoma, Non-Small-Cell Lung

Pancreatic Ductal Adenocarcinoma

Neoplasm Metastasis

Squamous Cell Carcinoma of Head and Neck

Brain Neoplasms

Rectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

Neoplasm Metastasis, Stomach Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

Carcinoma, Ovarian Epithelial

Carcinoma, Hepatocellular

Advanced Pancreatic Cancer

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular, Recurrence

Lung Neoplasms

Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Recurrence

Small Cell Lung Carcinoma

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Cholangiocarcinoma

Clinical Trials

The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.

CAREMM-2305

STARTNEWERA-OM

CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

TREATMENT

Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer

I-STOP

TRAILOCLORI01

QUASAR

RECORD

Thermal Ablation Followed by Immunotherapy for HCC

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCC

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma

Neoadjuvant Immunotherapy in Advanced NSCLC

A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

LBA-PI

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung Cancer

ACCORD

Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

Clinical Utilization of Newly Approved Oncology Medications